Chiara Brombin

Vita-Salute San Raffaele University

Papers

1

Total Citations

1

H-Index

1

About

Chiara Brombin is a leading researcher in the field of radiation oncology, with a primary focus on ultra-hypofractionated radiotherapy for prostate cancer. Her work centers on developing and validating innovative treatment protocols that dramatically reduce treatment duration without compromising efficacy. Brombin’s major contribution is the PRO-FAST protocol, a single-fraction, ablative, urethral-sparing, HDR-like robotic SBRT approach that compresses the entire prostate cancer treatment into a single day. This paradigm-shifting method, detailed in her 2025 paper, addresses a critical patient need for convenience and reduced hospital visits, while maintaining high tumor control. Although early in its citation history, this work represents a significant leap forward in the field. Brombin’s research is at the forefront of making radiotherapy more accessible and patient-friendly, potentially transforming standard care for localized prostate cancer. Her dedication to rigorous clinical investigation and technological innovation positions her as a key figure in the future of precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Comprehensive one-day management of prostate cancer patients: PRO-FAST single-fraction ablative, urethral-sparing, HDR-like, robotic SBRT
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Vita-Salute San Raffaele University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago